相关实验视频

Updated: Jan 8, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

克里斯普尔:一种精确的基因组编辑策略,用于治疗肝细胞癌

Subhrojyoti Mukherjee¹, Manish Kumar¹

¹Department of Pharmaceutics, ISF College of Pharmacy, Moga, India.

Expert review of anticancer therapy

|December 16, 2025

概括

基因编辑CRISPR提供了通过改变T细胞或癌细胞来治疗肝细胞癌 (HCC) 的新方法. 这项技术精确地针对遗传缺陷,改善癌症治疗结果和患者结果.

科学领域:

在瘤学瘤学.
基因编辑基因编辑
肝细胞癌研究肝细胞癌研究

背景情况:

肝细胞癌 (HCC) 预后不好,尽管最近的治疗进展.
迫切需要新的治疗方法来改善HCC患者的治疗结果.
克里斯普尔技术为癌症治疗中的基因改造提供了一个有希望的途径.

研究的目的:

审查CRISPR基因编辑技术在肝细胞癌 (HCC) 治疗中的应用.
分析正在进行的临床试验,并比较基于CRISPR的治疗方法与当前的治疗选择.
探索CRISPR在改善HCC治疗结果和患者结果方面的潜力.

主要方法:

审查正在进行的临床试验,涉及CRISPR治疗HCC.
在体内分析CRISPR在向癌细胞中的作用.
检查CRISPR介导的基因组抗原受体 (CAR) T细胞和T细胞受体 (TCR) T细胞的生成,用于HCC治疗.

主要成果:

克里斯普尔能够在适应性T细胞和恶性细胞中进行精确的基因改变,用于HCC治疗.
该技术有助于准导致癌症生长和转移的特定遗传异常.
基于CRISPR的策略,包括CAR T细胞和TCR T细胞,显示出增强HCC治疗的潜力.

结论:

基因编辑CRISPR为肝细胞癌提供了新的治疗替代方案.
该技术有可能通过精确向遗传缺陷,显著改善HCC治疗结果.
解决目前的障碍和实施安全措施对于CRISPR在HCC管理中的未来应用至关重要.

关键词:

这里是CRISPR系统的CRISPR系统.在CRISPR技术的应用中.肝细胞癌是肝细胞癌.仿真抗原受体T细胞的T细胞基因编辑基因编辑基因编辑工具是基因编辑工具.遗传操纵遗传操纵是一种转移转移转移转移

更多相关视频

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...